TRANSCRIPT TO FOLLOW
The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.
With central banks across the globe engaged in extensive QE programmes, this has put pressure ...
BlackRock's UK equity team explains why they are including growth stocks in their income fund
Silver Rated Franklin fund manager Colin Morton on the benefits of Brexit on UK equities, whet...
The current investment climate is tough for those seeking an income from their savings. We tal...
Data from Morningstar Direct reveals three Bronze Rated investment trusts providing some of th...
Mining companies are operating in a challenging environment but could now be the time to top up o...
THE WEEK: Morningstar columnist Rodney Hobson provides two pieces of advice to George Osborne, an...
Businesses that have competitive advantages within their industry are good candidates for dividen...
Morningstar reveals the top 10 best performers over the last five years
Morningstar OBSR reveals the top funds for investors seeking exposure to European equities
The semiconductor equipment maker's order level and the effects of Intel's problems are in focus
L&G Global 100 Index and JOHCM UK Equity Income are among the funds on track to beat their catego...
Consensus forecasts have CPI dipping last month to 2.1%, but still remaining above target
Pharmaceutical company to pay more than USD 2 billion to settle lawsuits over heartburn drug
Another interest rate cut of 0.25 percentage points next Thursday seems almost certain, but there...
Security Name | Price | Change (%) | Morningstar Rating |
---|---|---|---|
TB Saracen Global Income and Growth BAcc | 323.42 GBP | 0.38 |
Emma Wall is former Senior International Editor for Morningstar